ANIXA BIOSCIENCES, INC. Legal Fees
ANIXA BIOSCIENCES, INC. (ANIX) reported Legal Fees of $3.60 million for the 12-month period ending 2015-10-31, per its 10-K filed 2015-12-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2015-12-23
- ANIXA BIOSCIENCES, INC. legal fees for the quarter ending 2015-01-31 was $3.60M.
- ANIXA BIOSCIENCES, INC. legal fees for fiscal 2015 was $3.60M, a 0.00% change from fiscal 2014.
- ANIXA BIOSCIENCES, INC. legal fees for fiscal 2014 was $3.60M.
| Period end | Legal Fees 3 month | Legal Fees 12 month |
|---|---|---|
| 2015-10-31 | $3.60M 10-K · filed 2015-12-23 | |
| 2015-01-31 | $3.60M 10-Q · filed 2015-03-09 | |
| 2014-10-31 | $3.60M 10-K · filed 2015-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |